Protocol: A-102 Assessment of Vascular Reactivity by Novel Diagnostic Device, ANGIOEF-3000, compared to that using Brachial Artery Ultrasound Imaging -- Initial Experience in an Indian Population

Everist Genomics Inc0 个研究点目标入组 45 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•ECOG/Zubrod score performance status 0-1 (ECOG 0: Fully active, able to carry on all pre-disease performance without restriction; ECOG 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work)

•Refractory atrial fibrillation or multifocal atrial tachycardia;
•Frequent ventricular or atrial premature contractions;
•Myocardial infarction or unstable angina within previous 90 d;
•Congestive heart failure;
•Significant valvular heart disease;
•15 mm Hg or greater difference in systolic blood pressure between R and L arms;
•History of axillary-subclavian venous thrombosis;
•Arteriovenous fistula for hemodialysis;
•History of lymph node dissection;
•Diabetes mellitus for which subject is receiving insulin;
•Vasospastic disorders manifested by Raynaud's phenomenon;
•Active viral or bacterial infection;
•Prescribed any new medication or had medication dose modification within previous 4 wks;
•Body mass index greater than 50 kg/m2

发起方